Closing the diagnostic gap in uterine cancer

We are not waiting for women to become patients.

A foundation for early detection and prevention, built on a simple belief: women deserve to be seen before the symptoms begin.

Eva Tucci, smiling outdoors

Eva Gunilla Tucci, for whom this work is named.

Symptoms are not screening.

Endometrial cancer is the most common gynecologic cancer in the United States, yet unlike the Pap smear, there is still no routine early-detection paradigm. Too often, women are taught to wait for a warning sign. We are working to change that expectation.

The science

How little has changed.


For nearly a century, screening transformed the odds for one cancer after another. Uterine cancer was left behind, and the cost is rising.

Everyone else got a screening test. Women with uterine cancer still don't. OTHER CANCERS 1943 Pap test cervical 1969 Mammogram breast 1980s Colonoscopy colorectal 2000s HPV test cervical UTERINE CANCER Still no screening test · 2026
Major cancers gained a routine screening test decades ago. Uterine cancer still has none.1
Most cancer deaths are falling. This one keeps rising. U.S. cancer death rate, since 1991. 1991 today All cancers · deaths down a third Uterine cancer · deaths rising
The overall U.S. cancer death rate has fallen by about a third since 1991. Uterine cancer is one of the very few whose death rate is rising instead.1,4

Our evidence standard. Every statistic on this site is drawn from peer-reviewed research or major clinical guidelines, and cited. Our educational materials are developed with medical-advisory input, currently in formation. We do not publish anecdotal medical advice. When Amy shares her own experience, it is clearly labeled as her story.

Sources
  1. American Cancer Society. Cancer Facts & Figures 2025; Key Statistics for Endometrial Cancer (NCI SEER incidence, mortality, and survival data). cancer.org
  2. Giaquinto AN, et al. Cancer statistics for African American and Black people, 2025. CA: A Cancer Journal for Clinicians.
  3. American College of Obstetricians and Gynecologists. Updated guidance on the evaluation of postmenopausal bleeding, April 2026. acog.org
  4. Projected trends in the incidence and mortality of uterine cancer in the United States to 2050. Cancer Epidemiology, Biomarkers & Prevention (AACR), 2025.
Eva Tucci with her husband at the shore
Why we exist

A diagnosis moves through everyone who loves her.


In 1996, Eva was diagnosed with advanced endometrial cancer. Six months later, she was gone. When a woman is lost too soon, a daughter loses her mother, sons lose their center, a husband loses his partner, a whole family loses its sun.

The Eva Tucci Foundation was built from that loss, and from a conviction that earlier answers should not be a matter of luck.

Read the full story
Why your gift matters now

At the very beginning, every dollar goes further.

Uterine cancer is medically urgent and badly underfunded. We are small, new, and building the infrastructure of a movement from the ground up. That makes this the rare moment when a single gift helps decide what gets built.

$25

reaches more women with the warning signs that could save a life.

$100

funds the educational materials we put in front of women and clinicians.

$10/mo

keeps this work alive, issue after issue, woman after woman.

Donate now Give once, monthly, or in memory of someone you love. Your gift is tax-deductible to the fullest extent allowed by law. Registered 501(c)(3), EIN 41-5225790.
For our leadership donors

The Launch Fund.


We are raising our first $250,000 to build the foundation's first year, and to launch the "Symptoms Are Not Screening" campaign. Gifts from $1,000 to $100,000 each build a specific, named piece of the work.

Launch Fund underwayGoal: $250,000
What makes us different

Not a traditional cancer charity.


Before symptoms, not after

We focus upstream, on education and awareness that help women expect earlier evaluation, instead of being taught to wait until something is already wrong.

For the whole family

Cancer begins in a woman's body, but it changes daughters, sons, husbands, and fathers. We invite the people who love her into the conversation, including men and boys.

Building a new standard

We are not a single campaign or a single device. We are helping build the educational and behavioral infrastructure that makes early detection routine, understood, and expected.

#1
Most common gynecologic cancer in the U.S.
No
Routine screening test exists today, unlike cervical cancer
5
Coordinated program areas, working as one system
Test what you know

Myth, or fact?


Most women were never told the truth about uterine cancer. See how much you already know.

"A Pap smear screens for uterine cancer."

Myth

A Pap smear screens for cervical cancer. It does not reliably detect uterine cancer, and there is no routine screening test that does.

"Any bleeding after menopause is normal and not worth a visit."

Myth

Any bleeding after menopause is never normal. It is the most common warning sign of uterine cancer and should always be evaluated.

"Uterine cancer deaths are falling, like most cancers."

Myth

It is one of the very few cancers in the U.S. where deaths are rising, not falling, and the trend is projected to continue for decades.

"Obesity is the single biggest driver of rising uterine cancer."

Fact

True. Excess body fat raises estrogen that stimulates the uterine lining, and more than half of uterine cancers, around 57 percent, are attributable to it.

From the newsletter

Early detection, in plain language.


Loading the latest…

Get involved

Help build a future where women never have to wait.

Endometrial cancer is medically urgent and philanthropically under-served. That makes this the moment to make a visible, lasting difference, at the very beginning of a movement.